Axovant Sciences: Betting On An Improved Risk Profile

I took immediate notice when Axovant Sciences (AXON) went public back in late 2015. The promise of a treatment for Alzheimer’s was a huge opportunity, and I immediately had thoughts of my grandfather who struggled with the disease for years before he passed away with a heart attack. Yet, AXON had no revenues and no … Read more

Above the 40 (July 26, 2017) – A Stock Market Floating Higher And Still On the Edge

AT40 = 63.6% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 60.3% of stocks are trading above their respective 200DMAs VIX = 9.6 (volatility index) Short-term Trading Call: cautiously bullish Commentary The stock market had a relatively bland day that matched a relatively bland statement on monetary policy from the … Read more

Above the 40 (July 6, 2017) – A Stock Market Swivel

AT40 = 48.1% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 55.4% of stocks are trading above their respective 200DMAs VIX = 12.5 (volatility index) Short-term Trading Call: neutral Commentary Diabolically, the stock market has put my head on the proverbial swivel. I earlier noted how the NASDAQ in particular … Read more

T2108 Update (October 28, 2016) – Divergences Weigh Further on the Stock Market

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more